FDA Inspection 1133676 — Peter J. Winkle M.D.
The FDA completed an inspection of Peter J. Winkle M.D. on November 20, 2020 in Anaheim, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 20, 2020
- Fiscal Year
- 2021
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Anaheim, CA (United States)
Additional Details
Clinical Investigator (CI)